- Home
- Laboratory Diagnostics
- Assays by Diseases and Conditions
- Cardiac Assays
- Educational Material
Cardiac Testing Educational Material
A variety of resources to help keep you informed of the latest topics in cardiovascular disease testing.
Journal articles
- Role of High-sensitivity Troponin I in Diagnosing Acute Coronary Syndrome
- MLO Article - Diagnosis and Management of Patients with Heart Failure
- High-Sensitivity Troponin I Assays: A Breakthrough in AMI Diagnosis (pdf) 1.21 MB
- Chest Pain Management: High-sensitivity Cardiac Troponin Supports Rapid Assessment of Non-acute Myocardial Infarction Patients (Clinical Lab Int’l) (pdf) 3.86 MB
- Advantages of High-sensitivity Troponin I Assay (Diagnostic and Interventional Cardiology) (pdf) 0.12 MB
White papers
- High-Sensitivity Cardiac Troponin Testing in Accordance with the 2018 Fourth Universal Definition of Myocardial Infarction (pdf) 0.17 MB
- Performance Evaluation of the Atellica IM High-Sensitivity Troponin I Assay (pdf) 0.17 MB
- Analytical Performance of the Siemens Healthineers ADVIA Centaur High-Sensitivity Troponin I Assay (pdf) 0.29 MB
Videos
Cardiovascular Disease Videos
Siemens Healthineers is pleased to offer a series of educational videos focusing on the clinical utility of high-sensitivity troponin I. Hear leaders in the area of cardiovascular disease and laboratory diagnostics discuss the importance of implementing a high-sensitivity troponin I assay into their facility.
Webinars/Podcasts
AACC Sponsored Podcast: Laboratory and Clinical Perspectives
Understanding Findings of Sex-specific 99th Percentile URLs for High-sensitivity Cardiac Troponin Assays Derived from Universal Sample Bank
Selection of healthy reference populations and definition of exclusion criteria for deriving 99th percentiles for high-sensitivity cardiac troponin assays used in clinical practice and research vary considerably in the literature. We discuss the Universal Sample Bank findings regarding their clinical implications:
a) Sex-specific 99th percentiles varied according to the statistical method and hs-cTn assay used.
b) Not all assays provided measurable concentrations for women to qualify as hs assays.
c) Surrogate exclusion criteria used to define normality tended to lower 99th percentiles. Participants will learn that the decision concentrations used can affect diagnostics, risk-outcome assessments, and analytical characteristics.